Cargando…
Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma
SIMPLE SUMMARY: Overexpression of HER2 receptors have been identified in various types of cancer including breast cancer and ovarian cancer. HER2 overexpression is generally associated with poor clinical outcomes in patients with HER2-positve tumors. Trastuzumab, an antibody specifically targeting H...
Autores principales: | Maadi, Hamid, Soheilifar, Mohammad Hasan, Choi, Won-Shik, Moshtaghian, Abdolvahab, Wang, Zhixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303665/ https://www.ncbi.nlm.nih.gov/pubmed/34298754 http://dx.doi.org/10.3390/cancers13143540 |
Ejemplares similares
-
Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
por: Nami, Babak, et al.
Publicado: (2018) -
The Effects of Pertuzumab and Its Combination with Trastuzumab on HER2 Homodimerization and Phosphorylation
por: Nami, Babak, et al.
Publicado: (2019) -
A Novel Mechanism Underlying the Inhibitory Effects of Trastuzumab on the Growth of HER2-Positive Breast Cancer Cells
por: Maadi, Hamid, et al.
Publicado: (2022) -
Angioregulatory microRNAs in Colorectal Cancer
por: Soheilifar, Mohammad Hasan, et al.
Publicado: (2019) -
The effects of trastuzumab on HER2-mediated cell signaling in CHO cells expressing human HER2
por: Maadi, Hamid, et al.
Publicado: (2018)